• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about ESALF

    Recent news which mentions ESALF

    < Previous 1 2 Next >
    FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
    Tickers BIIB ESALF ESALY
    Tags Biotech BIIB Health Care
    From Benzinga
    Medicare unveils plan for coverage of new Alzheimer’s drugs
    Tickers BIIB ESALF LLY
    Tags ESALF LLY BIIB
    From MarketWatch
    Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
    Tickers BIIB ESALF ESALY LLY
    Tags General ESALY News
    From Benzinga
    Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
    Tickers BIIB ESALF ESALY LLY
    Tags Government General ESALY
    From Benzinga
    Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
    Tickers ESALF ESALY MRK
    Tags ESALY News Briefs
    From Benzinga
    National Institute on Aging Aims Building $300M Alzheimer's Research Database
    Tickers BIIB ESALF ESALY
    Tags Alzheimer’s Market News Benzinga
    From Benzinga
    Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
    Tickers BIIB ESALF ESALY
    Tags General Health Care BIIB
    From Benzinga
    Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
    Tickers BIIB ESALF ESALY LLY
    Tags ESALF ESALY Regulations
    From Benzinga
    Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
    Tickers BIIB ESALF ESALY
    Tags Market News Benzinga Large Cap
    From Benzinga
    Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
    Tickers BIIB ESALF ESALY
    Tags General ESALY News
    From Benzinga
    The 7 Best Growth Stocks to Buy for February 2023
    Tickers ACLS CPRX DAR ESALF
    Tags TEVA CPRX Market News
    From InvestorPlace
    New Alzheimer’s drug shows some promise, but has big price tag
    Tickers BIIB ESALF
    Tags BIIB JP:4523 ESALF
    From MarketWatch
    FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
    Tickers BIIB ESALF ESALY
    Tags ESALF General Briefs
    From Benzinga
    Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
    Tickers BIIB ESALF ESALY
    Tags Market News Benzinga Large Cap
    From Benzinga
    Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
    Tickers CPRX ESALF ESALY
    Tags General M&A News
    From Benzinga
    Despite Safety Concerns, Analysts Are Bullish On Biogen's Second Alzheimer's Candidate
    Tickers BIIB ESALF ESALY
    Tags Health Care BIIB Large Cap
    From Benzinga
    Open Questions On Safety Lingers After Eisai-Biogen's Detailed Lecanemab Data For Alzheimer's
    Tickers BIIB ESALF ESALY
    Tags Market News Benzinga Biotech
    From Benzinga
    Biogen's Potential Early Alzheimer's Treatment Sees Second Death Linked To It, Shares Fall
    Tickers BIIB ESALF ESALY
    Tags Market News Benzinga Trading Ideas
    From Benzinga
    One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments
    Tickers BIIB ESALF LLY MOR
    Tags LLY PRTA ESALF
    From MarketWatch
    Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
    Tickers BIIB ESALF ESALY MOR
    Tags Large Cap BIIB Market News
    From Benzinga
    Despite Advancement, Benefits From Alzheimer's Drugs May Be Limited, Say Researchers
    Tickers BIIB ESALF ESALY LLY
    Tags ESALF Top Stories ESALY
    From Benzinga
    Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
    Tickers BIIB ESALF SPX
    Tags JP:4523 BIIB ESALF
    From MarketWatch
    Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
    Tickers ESALF ESALY MRK
    Tags General Briefs News
    From Benzinga
    Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
    Tickers ESALF ESALY LLY RHHBF
    Tags RHHVF RHHBF ESALF
    From Benzinga
    Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
    Tickers ESALF ESALY MRK
    Tags ESALF News Briefs
    From Benzinga
    The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
    Tickers AMTI BIIB ESALF ESALY
    Tags BIIB EVOTF Benzinga
    From Benzinga
    The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
    Tickers AGEN ARWR ATNX AVGR
    Tags FDA IMUX ITCI
    From Benzinga
    Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
    Tickers BIIB ESALF ESALY
    Tags ESALF ESALY News
    From Benzinga
    Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
    Tickers BIIB ESALF ESALY
    Tags ESALF General ESALY
    From Benzinga
    FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
    Tickers ESALF ESALY MRK
    Tags General News Briefs
    From Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.